
Naivex 50mg Tablet
Salt Composition: Dolutegravir
Expiry Date: 01/2028
Inclusive of all taxes
30 tablet
About The Product
HIV
Naivex 50mg Tablet is a prescription-based antiviral medicine. It is used in the treatment of HIV (Human immunodeficiency virus) infection. This medication helps to reduce the amount of HIV in your body and improves the quality of life. Naivex, comprising Dolutegravir, is an HIV-1 antiviral agent. It works to inhibit HIV integrase and binds to the active site. It is important to take this medicine as prescribed by your doctor.
Side Effects
- Most side effects of the Naivex 50mg Tablet do not require medical attention, as they typically resolve as your body adjusts to the medication.
- While the effects of the medicine can differ among patients, everyone must be informed about them.
- Some common side effects include: Headache Insomnia Dizziness Nausea Fatigue Muscle pain Skin rash Itching Fever Chills Contact your doctor immediately if you experience any severe or unusual side effects.
How To Use
- The doctor will determine the appropriate dosage of Naivex 50mg Tablet based on the patient's health and medical conditions.
- It is important to take this medication at the same time each day as prescribed by your doctor to achieve the best results.
- You can take it orally, either with or without food.
- If you suspect an overdose, contact your doctor immediately.
Safety Advice
Missed Doses
- It is advisable not to miss a dose.
- If you miss a scheduled dose of Naivex tablets, contact your doctor immediately.
Reference
1. Turkova, A., White, E., Mujuru, H.
A., Kekitiinwa, A. R., Kityo, C.
M., Violari, A., ... & Gibb, D. M.
(2021). Dolutegravir as first-or second-line treatment for HIV-1 infection in children.
New England Journal of Medicine, 385(27), 2531-2543. 2.
Venter, W. D., Moorhouse, M., Sokhela, S., Fairlie, L., Mashabane, N., Masenya, M., ... & Hill, A.
(2019). Dolutegravir plus two different prodrugs of tenofovir to treat HIV.
New England Journal of Medicine, 381(9), 803-815. 3.
Katlama, C., & Murphy, R. (2012).
Dolutegravir for the treatment of HIV. Expert opinion on investigational drugs, 21(4), 523-530.
4. Rhee, S.
Y., Grant, P. M., Tzou, P.
L., Barrow, G., Harrigan, P. R., Ioannidis, J.
P., & Shafer, R. W.
(2019). A systematic review of the genetic mechanisms of dolutegravir resistance.
Journal of Antimicrobial Chemotherapy, 74(11), 3135-3149. 5.
Kandel, C. E., & Walmsley, S.
L. (2015).
Dolutegravir–a review of the pharmacology, efficacy, and safety in the treatment of HIV. Drug design, development and therapy, 3547-3555.
FAQs
Naivex 50mg Tablet is an antiviral medication that prevents the human immunodeficiency virus (HIV) from multiplying in your body.
This tablet also helps to delay the production of HIV infection and improve the quality of life.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
